Company: AXS-PE
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001214816-25-000056
Chunk: 254

Company: AXIS CAPITAL HOLDINGS LTD
Filing Date: 2025-02-26
Form: 10-K
Item: Item 1A
Chunk 254
---
 impose additional prohibitions or compliance obligations on our dealings in certain countries and territories, including sanctions imposed on Russia and certain Ukraine territories. In addition, we are subject to the Foreign Corrupt Practices Act and other anti-bribery laws, such as the Irish Criminal Justice (Corruption Offences) Act, the Bermuda Bribery Act and the U.K. Bribery Act, which generally bar corrupt payments or unreasonable gifts. Although we have policies and controls in place that are designed to ensure compliance with these laws and regulations, it is possible that an employee or an agent acting on our behalf could fail to comply with applicable laws and regulations and, due to the complex nature of the risks, it may not always be possible for us to ascertain compliance with such laws and regulations. In such event, we could be exposed to civil penalties, criminal penalties and other sanctions, including fines or other unintended punitive actions. In addition, such violations could damage our business and/or our reputation. All of the foregoing could have a material adverse effect on our financial condition and operating results.

46

Risks Related to the Ownership of our Securities

In addition to the risks to our business listed above, there are certain other risks related to the ownership of our securities.

The price of our common shares may be volatile.

There has been significant volatility in the market for equity securities in recent years. During 2024, 2023, and 2022, the closing price of our common shares fluctuated from a low of $54.27 to a high of $94.05, a low of $51.68 to a high of $63.47, and a low of $48.77 to a high of $60.66, respectively. The price of our common shares may not remain at or exceed current levels. The following factors, in addition to those described in other risk factors above, may have a material adverse effect on the market price of our common stock:

•actual or anticipated variations in our quarterly results, including as a result of catastrophes or our investment performance; 

•any share repurchase program; 

•changes in market valuation of companies in the insurance/reinsurance industry; 

•changes in expectations of future financial performance or changes in estimates of securities analysts; 

•fluctuations in stock market processes and volumes; 

•issuances or sales of common shares or other securities in the future; 

•the addition or departure of key personnel;

•changes in tax law; and

•announcements by us or our competitors of